Stockreport

Natera Announces Broad Clinical Launch of Ultra-Sensitive Signatera™ Genome MRD Test

Natera, Inc.  (NTRA) 
Last natera, inc. earnings: 2/26 04:10 pm Check Earnings Report
US:NASDAQ Investor Relations: investor.natera.com
PDF Extensive pan-cancer validation data from over 3,000 plasma samples to be presented at ASCO AUSTIN, Texas--(BUSINESS WIRE)--Natera, Inc. (NASDAQ: NTRA), a global lead [Read more]